• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research Report on Chinese Anti-Tumor Drug Market, 2009 Product Image

Research Report on Chinese Anti-Tumor Drug Market, 2009

  • Published: March 2009
  • Region: China
  • 60 Pages
  • China Research & Intelligence

With the deterioration of natural environment and the bad eating habits, there is an increasing number in Chinese malignant tumor patients. At present, the outbreak rate of Chinese male malignant tumors are 130.3 to 305.4 per one hundred thousand, and female of 39.5 to 248.7 per one hundred thousand. In 2008, the new cancer case loads in China exceeded 2.2 million and over 1.6 million deaths. In recent years, one in every four to five deaths is died of cancer, the leading cause of death. It is predicted that there will be 5.5 million new cancer case loads in 2020 in China and the deaths will reach to four million.

With the growing outbreaks of malignant tumor, the cure measures for cancer are advanced too as well as the 5-year survival rate of cancer patients. The cure of malignant tumor also brings the development of the anti-tumor drug market. In recent years, the scales of Chinese anti-tumor drug market have been rising. The sales of anti-tumor drugs in Chinese hospitals are keeping steady growth and making the breakthrough of 5 billion USD in 2007.

China has approved about two hundred kinds of anti-tumor drugs in the market, about 100 kinds for various cancer treatments. READ MORE >

1 Related Concepts of Anti-Tumor Drugs
1.1 Categories of Common Anti-Tumor Drugs
1.2 Actions of Anti-Tumor Drugs

2 Overview on Chinese Anti-Tumor Drug Market, 2008
2.1 Analysis on the Tumor Diseases
2.1.1 Analysis on the Outbreaks
2.1.2 Analysis on the Outbreak Trends
2.2 Analysis on Chinese Anti-Tumor Drug Market
2.2.1 Overview
2.2.2 Market Scales
2.2.3 Characteristics of the Market Structure

3 Analyses on the Major Anti-Tumor Drug Market in Chinese Market
3.1 Alkylation Agent Anti-Tumor Drug Market in Chinese Market
3.1.1 Ifosfamide
3.1.2 SarCNU
3.2 Antibiotics Anti-Tumor Drug Market in Chinese Market
3.3 Anti-metabolite Drug Market in Chinese Market
3.4 Plants Extract Anti-Tumor Drug Market in Chinese Market
3.5 Hormone Anti-Tumor Drug Market in Chinese Market
3.6 Other Anti-Tumor Drug Market in Chinese Market

4 Analyses on Traditional Chinese Anti-Tumor Drug Market
4.1 Overview on Traditional Chinese Anti-Tumor Drug Market
4.2 Traditional Chinese Anti-Tumor Drugs
4.3 Traditional Chinese Medicine-aided Anti-Tumor Drugs
4.4 Trends of Traditional Chinese Anti-Tumor Drug Market

5 Major Manufacturers of Chinese Anti-Tumor Drug Market, 2008
5.1 Company A
5.1.1 Company Profiles
5.1.2 Productions
5.1.3 Development Strategies
5.2 Company B
… …

6 Analyses on the Development of Chinese Anti-Tumor Drug Market, 2009-2010
6.1 Analysis on the Trends of Chinese Anti-Tumor Drug Market
6.2 Analysis on the Technology Trends of Chinese Anti-Tumor Drug Market
6.2.1 Western-style Pharmaceuticals
6.2.2 Traditional Chinese Medicines
6.3 Recommendations for the Investment and Development of Chinese Anti-Tumor Drug Market

Selected Charts
Chart Contents of Anti-Tumor Drugs in Chinese Market
Chart Contents of Common Anti-Tumor Drugs in Chinese Market
Chart Mortality Rates of Chinese Tumor Patients, 2003-2008
Chart Scales of International Anti-Tumor Drug Market, 2003-2008
Chart Scales of Chinese Anti-Tumor Drug Market, 2003-2008
Chart Western-style Anti-Tumor Drugs in the Contents of Chinese Basic Medical Insurance Medicines
Chart Chinese Traditional Anti-Tumor Drugs in the Contents of Chinese Basic Medical Insurance Medicines

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos